Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.
Perihal
GlaxoSmithKline Consumer Healthcare Limited manufactures and sells malt based foods, protein rich foods, and cereal based beverages in India. The company offers health food drinks and biscuits under the Horlicks, Boost, Viva, and Maltova brand names; Ostocalcium, a calcium supplement; ENO, an antacid for acidity; Crocin, a non?prescription analgesics drug; and Iodex, a balm for neck/shoulder pain, back pain, joint pain, sprain, etc. It also provides Crocin Cold & Flu, which provides relief from headache, body aches and pains, and sore throat, as well as pain associated with sinusitis, nasal, and sinus congestion; and Otrivin, a nasal decongestant that provides relief from blocked nose. In addition, the company offers toothpaste for sensitive teeth under the Sensodyne name; and prescription medicines for a range of therapeutic areas, as well as vaccines for the prevention of life-threatening diseases. It also exports its products to Bangladesh, Sri Lanka, the Middle East, Myanmar, Kenya, Mauritius, and Pakistan. GlaxoSmithKline Consumer Healthcare Limited has a strategic collaboration with InveniAI LLC. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurugram, India.
Show more...
CEO
Mr. Navneet Saluja
Pekerja
3844
Negara
India
ISIN
INE264A01014
Penyenaraian
0 Comments
Kongsi pendapat anda
FAQ
Berapakah harga saham GlaxoSmithkline Consumer Healthcare hari ini?▼
Harga semasa GSKCONS.NSE ialah ₹10,675.5 INR — telah meningkat sebanyak +4.29% dalam 24 jam yang lalu. Pantau prestasi harga saham GlaxoSmithkline Consumer Healthcare dengan lebih dekat pada carta.
Apakah simbol saham GlaxoSmithkline Consumer Healthcare?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham GlaxoSmithkline Consumer Healthcare didagangkan di bawah simbol GSKCONS.NSE.
Bagaimanakah keputusan kewangan GlaxoSmithkline Consumer Healthcare pada suku lepas?▼
Keputusan kewangan GSKCONS.NSE bagi suku terakhir ialah 45.75 INR sesaham, manakala anggaran ialah 46.93 INR, menghasilkan kejutan sebanyak -2.51%. Anggaran keputusan bagi suku berikutnya ialah Tiada INR sesaham.
Berapakah hasil GlaxoSmithkline Consumer Healthcare untuk tahun lepas?▼
Hasil GlaxoSmithkline Consumer Healthcare untuk tahun lalu berjumlah 25.39B INR.
Berapakah pendapatan bersih GlaxoSmithkline Consumer Healthcare untuk tahun lepas?▼
Pendapatan bersih GSKCONS.NSE untuk tahun lepas ialah 5.93B INR.